CartiHeal

3 stories about CartiHeal
צוות עובדי קרטיהיל בישראל

Biomed company CartiHeal acquired by Smith & Nephew for up to $330 million

22.11.23|Meir Orbach
The Israeli firm, which develops a biocompatible, coral-based, off-the-shelf implant for damaged joints, will initially receive $180 million in cash and up to a further $150 million contingent on financial performance
ביו-ונטוס ביוונטוס Bioventus  קנתה את קרטיהיל Cartiheal

Israeli medtech company CartiHeal to be acquired for $500 million by Bioventus

30.08.21|Golan Hazani
The American orthobiologics company announced that it has activated its option to purchase the Kfar Saba-based company by transferring an initial $50 million
בניין ה בורסה משכן חדש רחוב אחוזת בית תל אביב

Biomed Company CartiHeal Considers a Nasdaq IPO

26.02.20|Golan Hazani
The company is looking to raise between $60 million and $80 million according to a valuation of $300 million to $400 million and has already hired Credit Suisse and Jefferies for this purpose, according to two people familiar with the matter